Sort
48,018 grants matching “immunotherapy”
Project 3: Development of Novel Therapies and Biomarkers for TNBC Patients
$358,272Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Biocontained ImageStream 100 Multispectral Imaging Cytometer
$358,201Judy Lieberman · Immune Disease Institute, Inc. · S10 · FY2007 · RR
Deciphering the function of DNp63 and MDSCs in tumor promotion and metastasis of TNBCs
$358,131Rumela Chakrabarti · University Of Miami School Of Medicine · R01 · FY2023 · CA
Molecular Mechanisms of Immune Tolerance
$358,131Roberta Pelanda · National Jewish Health · T32 · FY2020 · AI
Deciphering the function of DNp63 and MDSCs in tumor promotion and metastasis of TNBCs
$358,129Rumela Chakrabarti · University Of Miami School Of Medicine · R01 · FY2022 · CA
New Peptides for the Treatment of Multiple Sclerosis
$358,102Christine Beeton · Baylor College Of Medicine · R01 · FY2014 · NS
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
$358,098Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2021 · CA
Pathogenesis and Treatment of Anaphylaxis
$358,090Melody C Carter · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Towards the identification of biomarkers for pediatric milk allergy
$358,085Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2022 · AI
Multiplex matrix ELISA for T cell protein-interaction networks in cancer
$358,081Adam G. Schrum · University Of Missouri-Columbia · R33 · FY2020 · CA
Biomaterials Approach to Expand Hematopoietic Cells ex vivo
$358,077Kam W Leong · Duke University · R01 · FY2007 · HL
Biomaterials Approach to Expand Hematopoietic Cells ex vivo
$358,076Kam W Leong · Duke University · R01 · FY2009 · HL
Biomaterials Approach to Expand Hematopoietic Cells ex vivo
$358,074Kam W Leong · Duke University · R01 · FY2008 · HL
IMMUNE MONITORING CORE
$358,055Trudy Nan Small · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
The Immunobiology of Marrow Allografts for Leukemia
$358,014Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Characterization of Fuctional Defective Autoimmune Human CD4+CD25+ Tregs
$358,007David A. Hafler · Yale University · U19 · FY2010 · AI
Tolerogenic DC as Therapeutic Agents in GVHD
$358,000Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2010 · AI
Tolerogenic DC as Therapeutic Agents in GVHD
$358,000Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2009 · AI
Targeting TIGIT and PD-1 in Melanoma
$357,994Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$357,994Laurie E Littlepage · University Of Notre Dame · R01 · FY2025 · CA
Role of ICAM1 in development and progression of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2020 · CA
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$357,994Laurie E Littlepage · University Of Notre Dame · R01 · FY2021 · CA
Targeting TIGIT and PD-1 in Melanoma
$357,994Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
DNA damage signaling to dormant origins of replication
$357,994Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$357,994Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA